Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Ali AS et al. |
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
|
2 |
Aula H et al. |
Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study.
|
3 |
Boman E et al. |
Importance of deformable image registration and biological dose summation in planning of radiotherapy retreatments.
|
4 |
Boman E et al. |
The robustness of dual isocenter VMAT radiation therapy for bilateral lymph node positive breast cancer.
|
5 |
Boman E et al. |
The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments.
|
6 |
Cohen R et al. |
Immune checkpoint inhibitors for patients with colorectal cancer: mismatch repair deficiency and perspectives.
|
7 |
Ducreux M et al. |
Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer -A definite conclusion?
|
8 |
Forsgård R et al. |
Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats.
|
9 |
Fortner R et al. |
Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.
|
10 |
Guren T et al. |
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.
|
11 |
Hietanen T. |
The Effects of Irradiation, Hyper-, and Hypothermia on Viability and Cytotoxicity of Natural Killer Cells.
|
12 |
Hippeläinen E et al. |
Ejection fraction in myocardial perfusion imaging assessed with a dynamic phantom: comparison between IQ-SPECT and LEHR.
|
13 |
Joensuu H et al. |
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
|
14 |
Kaartinen I et al. |
Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
|
15 |
Kallio J et al. |
Resistin and interleukin-6 as predictive factors for recurrence and long-term prognosis in renal cell .
|
16 |
Kapanen M et al. |
Effects of multiple breath hold reproducibility on treatment localization and dosimetric accuracy in radiotherapy of left-sided breast cancer with voluntary deep inspiration breath hold technique.
|
17 |
Korkeila E et al. |
Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.
|
18 |
Lehto J et al. |
Undergraduate curriculum in palliative medicine at Tampere University increases students' knowledge.
|
19 |
Lemma S et al. |
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
|
20 |
Mäkitie A et al. |
Head and neck cancer management in the Nordic countries: an effort to harmonize treatment.
|
21 |
Niemelä J et al. |
Measurement and properties of the dose-area product ratio in external small-beam radiotherapy.
|
22 |
Orell-Kotikangas H et al. |
Cachexia at diagnosis is associated with poor survival in head and neck cancer patients.
|
23 |
Partanen M et al. |
Comparison of two Monte Carlo-based codes for small-field dose calculations in external beam radiotherapy.
|
24 |
Rajala K et al. |
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis.
|
25 |
Saukkonen M et al. |
Syöpäpotilaan ja hänen läheisensä selviytymistä edistävät tekijät palliatiivisen hoidon aikana.
|
26 |
Seppälä J et al. |
Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
|
27 |
Sormunen J et al. |
Cohort profile: a nationwide cohort of Finnish military recruits born in 1958 to study the impact of lifestyle factors in early adulthood on disease outcomes.
|
28 |
Sunela K. |
Follikulaarisen lymfooman nykyhoito.
|
29 |
Sunela K. |
Luganon 14. kansainvälinen lymfoomakonferenssi.
|
30 |
Tiirola A et al. |
End-of-Life Care of Patients With Amyotrophic Lateral Sclerosis and Other Nonmalignant Diseases.
|
31 |
Trovik C et al. |
The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.
|
32 |
Tuohinen S et al. |
Detection of early radiotherapy-induced changes in intrinsic myocardial contractility by ultrasound tissue characterization in patients with early-stage breast cancer.
|
33 |
Tuohinen S et al. |
Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: speckle tracking echocardiography study.
|
34 |
Turcotte M et al. |
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
|
35 |
Väänänen T et al. |
High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
|
36 |
Winther S et al. |
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.
|
37 |
Wu X et al. |
Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
|
38 |
Wu X et al. |
The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy.
|
39 |
Wu X et al. |
Correlation between apparent diffusion coefficient value on diffusion weighted MR imaging and Gleason score in prostate cancer.
|
40 |
Ålgars A et al. |
EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
|